Table 1 Baseline characteristics
Total (n = 512) | Elective (n = 378) | Non-elective (n = 134) | P-value | |
|---|---|---|---|---|
Age [years] | 82.0 (78.7–85.3) | 81.8 (78.7–84.9) | 83.4 (78.4–86.0) | 0.067 |
Female, n [%] | 237 (46.3) | 165 (43.7) | 72 (53.7) | 0.044 |
BMI [kg/m2] | 26.1 (23.5–29.4) | 26.0 (23.8–29.3) | 26.7 (23.4–30.7) | 0.399 |
CAD, n [%] | 322 (62.9) | 238 (63.0) | 84 (62.7) | 0.955 |
COPD, n [%] | 59 (11.5) | 43 (11.4) | 16 (11.9) | 0.860 |
CVD, n [%] | 66 (12.9) | 43 (11.4) | 23 (17.2) | 0.086 |
STS-score [%] | 3.1 (2.3–4.9) | 3.0 (2.2–4.4) | 4.2 (2.5–5.9) | < 0.001 |
Diabetes mellitus, n [%] | 170 (33.2) | 117 (31.0) | 53 (39.6) | 0.069 |
Dyslipidaemia, n [%] | 316 (61.7) | 228 (60.3) | 88 (65.7) | 0.273 |
History of AF, n [%] | 219 (42.8) | 151 (39.9) | 68 (50.7) | 0.030 |
Hypertension, n [%] | 473 (92.4) | 347 (91.8) | 126 (94.0) | 0.403 |
NYHA class IV on admission | 59 (11.5) | 30 (7.9) | 29 (21.6) | < 0.001 |
PAD, n [%] | 42 (8.2) | 30 (7.9) | 12 (9.0) | 0.712 |
PH (sPAP > 55 mmHg), n [%] | 76 (14.8) | 49 (13.0) | 27 (20.1) | 0.049 |
LVEF < 55%, n [%] | 204 (39.8) | 158 (41.8) | 46 (34.3) | 0.129 |
Prev. cardiac surgery, n [%] | 87 (17.0) | 62 (16.4) | 25 (18.7) | 0.550 |
Frailty syndromea, n [%] | 150 (29.3) | 61 (16.1) | 89 (66.4) | < 0.001 |
eGFR < 60 mL/min/1.73m2, n [%] | 311 (60.7) | 210 (55.6) | 101 (75.4) | < 0.001 |
Creatinine [µmol/L] | 100 (82–133) | 95 (81–124) | 115 (93–154) | < 0.001 |
hs-TNT [pg/mL] | 25.6 (15.4–45.1) | 22.3 (14.8–37.7) | 45.5 (24.7–115.4) | < 0.001 |
NT-proBNP [pg/mL] | 1072 (433–2770) | 835 (398–2036) | 2233 (924–5539) | < 0.001 |
AVA [cm2] | 0.8 (0.6–0.9) | 0.8 (0.6–0.9) | 0.7 (0.6–0.9) | 0.286 |
MPG [mmHg] | 38 (29–48) | 38 (29–47) | 38 (28–50) | 0.901 |
MR III–IV, n [%] | 12 (2.3) | 6 (1,6) | 6 (4,5) | 0.089 |
TR III–IV, n [%] | 19 (3.7) | 9 (2.4) | 10 (7.5) | 0.014 |